Cargando…

Advanced glycation end products and their receptors in serum of patients with type 2 diabetes

Glycation is a non-enzymatic process involving the reaction of reducing sugars or reactive oxoaldehyde with proteins, lipids or nucleic acids, which results in the formation of advanced glycation end products (AGEs). The presented work discusses the glycation process in people with advanced stage of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indyk, Diana, Bronowicka-Szydełko, Agnieszka, Gamian, Andrzej, Kuzan, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225908/ https://www.ncbi.nlm.nih.gov/pubmed/34168187 http://dx.doi.org/10.1038/s41598-021-92630-0

Ejemplares similares

Advanced glycation end products as a source of artifacts in immunoenzymatic methods
por: Kuzan, Aleksandra, et al.
Publicado: (2018)

Alcoholic Liver Disease Is Associated with Elevated Plasma Levels of Novel Advanced Glycation End-Products: A Preliminary Study
por: Litwinowicz, Kamil, et al.
Publicado: (2022)

Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
por: Bronowicka-Szydełko, Agnieszka, et al.
Publicado: (2021)

Association of Novel Advanced Glycation End-Product (AGE10) with Complications of Diabetes as Measured by Enzyme-Linked Immunosorbent Assay
por: Bronowicka-Szydełko, Agnieszka, et al.
Publicado: (2021)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence
por: Zubchenko, Svitlana, et al.
Publicado: (2022)

The melibiose-derived glycation product mimics a unique epitope present in human and animal tissues
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis
por: Litwinowicz, Kamil, et al.
Publicado: (2021)

Analysis of the Site-Specific Myoglobin Modifications in the Melibiose-Derived Novel Advanced Glycation End-Product
por: Gostomska-Pampuch, Kinga, et al.
Publicado: (2022)

Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology—A Pilot Study
por: Kuzan, Aleksandra, et al.
Publicado: (2021)

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
por: Barzilay, Joshua I., et al.
Publicado: (2014)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
por: Zawada, Agnieszka, et al.
Publicado: (2022)

Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor
por: Rzepka, Rafał, et al.
Publicado: (2015)

Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
por: Du, Chenping, et al.
Publicado: (2022)

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
por: Lee, Alan C. H., et al.
Publicado: (2015)

Chronic Spontaneous Urticaria Is Characterized by Lower Serum Advanced Glycation End-Products
por: Grzanka, Alicja, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

How Diabetes and Other Comorbidities of Elderly Patients and Their Treatment Influence Levels of Glycation Products
por: Kuzan, Aleksandra, et al.
Publicado: (2022)

Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011)

Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2012)

Serum Levels of Advanced Glycation End Products Are Associated with In-Stent Restenosis in Diabetic Patients
por: Choi, Eui-Young, et al.
Publicado: (2005)

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients
por: Lobo, João Paulo, et al.
Publicado: (2017)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Advanced Glycation End Products, Diabetes, and Bone Strength
por: Yamamoto, Masahiro, et al.
Publicado: (2016)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
por: Oshitari, Toshiyuki
Publicado: (2023)

Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy
por: Sourris, Karly C., et al.
Publicado: (2010)

Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes
por: Leung, Sherman S., et al.
Publicado: (2023)

Advanced Glycation End Products in Children With Type 1 Diabetes: Family Matters?
por: Barat, Pascal, et al.
Publicado: (2012)

Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
por: Nowotny, Kerstin, et al.
Publicado: (2015)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021)

Advanced glycation end products regulate the receptor of AGEs epigenetically
por: Wu, Xiaoqing, et al.
Publicado: (2023)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
por: Czech, Monika, et al.
Publicado: (2021)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
por: Twarda-Clapa, Aleksandra, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
por: Asadipooya, Kamyar, et al.
Publicado: (2019)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment
por: Chen, Gang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p66avobnqoq656uo3qrs0ql09a